MilliporeSigma develops alternative CRISPR methodFeedstuffsMilliporeSigma announced May 17 that it developed a new genome editing tool that makes CRISPR more efficient, flexible and specific, giving researchers more experimental options and faster resu… Continue reading
|
This UK Biotech uses CRISPR-Cas9 Against Bacterial Resistance
Labiotech.eu (blog) Swiss Bioversys is testing a similar approach, although the biotech’s platform is based on small molecules. Also, Nemesis’ technology represents yet another exciting therapeutic application of the CRISPR-Cas9 system. Because the endonuclease is … |
|
Celyad Announces First Quarter 2017 Business Update
GlobeNewswire (press release) Patrick Jeanmart, CFO of Celyad added: “The decision of the USPTO to uphold our patent related to allogeneic TCR-deficient CAR–T cells confirmed the strength of our intellectual property, and our license agreement with Novartis demonstrated the … |
KIRO Seattle |
Gene replacement therapy that works in dogs to be tested in children
KIRO Seattle In video obtained by KIRO 7, dogs that were destined to die show no signs of the disease after a single infusion of gene-replacement therapy. The disease is so deadly in children, 50-percent of them die before their second birthday. “This is a huge deal. |